STJ St. Jude Medical Inc.
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
- 20.81 P/E
- 3.66 P/S
- 5.31 P/B
- 3.51 EPS
- 14.54% Cash ROIC
- 0.54 Cash Ratio
- 1.16 / 1.60 % Dividend
- 1.53M Avg. Vol.
- 281.18M Shares
- 20.54B Market Cap.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
Business Wire (press release) - 4 hours ago
Vanguard Tribune - 39 minutes ago
TheStreet.com - Jun 22, 2015
St. Jude Medical, Inc. to Issue Quarterly Dividend of $0.29 on July 31st (STJ) - Mideast Time
Business Wire (press release) - Jun 8, 2015
Stock Markets Daily - Jun 11, 2015
Morningstar Assigns "AA-" Credit Rating to St. Jude Medical (STJ) - Dakota Financial News
Zacks.com - Jun 12, 2015
Reuters - Jun 12, 2015
FDA approves brain implant to help reduce Parkinson's disease and essential ... - FDA.gov
American Trade Journal - Jun 29, 2015
Zacks.com - Jun 5, 2015
New St. Jude device treats chronic pain using an iPod - Minneapolis Star Tribune
MarketWatch - Jun 25, 2015